- Home
- BPOPM vs OABI Comparison
BPOPM vs OABI Comparison
Compare BPOPM & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPOPM
- OABI
- Stock Information
- Founded
- BPOPM N/A
- OABI 2012
- Country
- BPOPM United States
- OABI United States
- Employees
- BPOPM N/A
- OABI N/A
- Industry
- BPOPM Major Banks
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- BPOPM Finance
- OABI Health Care
- Exchange
- BPOPM Nasdaq
- OABI Nasdaq
- Market Cap
- BPOPM N/A
- OABI 185.9M
- IPO Year
- BPOPM N/A
- OABI N/A
- Fundamental
- Price
- BPOPM $24.58
- OABI $1.27
- Analyst Decision
- BPOPM
- OABI Strong Buy
- Analyst Count
- BPOPM 0
- OABI 3
- Target Price
- BPOPM N/A
- OABI $7.00
- AVG Volume (30 Days)
- BPOPM N/A
- OABI 814.0K
- Earning Date
- BPOPM N/A
- OABI 05-08-2025
- Dividend Yield
- BPOPM N/A
- OABI N/A
- EPS Growth
- BPOPM N/A
- OABI N/A
- EPS
- BPOPM N/A
- OABI N/A
- Revenue
- BPOPM N/A
- OABI $26,744,000.00
- Revenue This Year
- BPOPM N/A
- OABI N/A
- Revenue Next Year
- BPOPM N/A
- OABI $40.06
- P/E Ratio
- BPOPM N/A
- OABI N/A
- Revenue Growth
- BPOPM N/A
- OABI 27.07
- 52 Week Low
- BPOPM N/A
- OABI $1.22
- 52 Week High
- BPOPM N/A
- OABI $4.96
- Technical
- Relative Strength Index (RSI)
- BPOPM 21.69
- OABI 27.15
- Support Level
- BPOPM $25.20
- OABI $1.35
- Resistance Level
- BPOPM $25.46
- OABI $1.41
- Average True Range (ATR)
- BPOPM 0.14
- OABI 0.09
- MACD
- BPOPM -0.09
- OABI 0.00
- Stochastic Oscillator
- BPOPM 0.00
- OABI 12.20
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.